Name (Synonyms) | Correlation | |
---|---|---|
drug2846 | Telehealth CBT Wiki | 1.00 |
drug2692 | Standard care Wiki | 0.35 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The COVID-19 pandemic is of grave concern due its impact on human health and on the economy. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory, immunomodulatory, anti-oxidant properties, and various aspects of the SARS-CoV-2 infection mechanism are potential targets for propolis compounds. Propolis components have inhibitory effects on the ACE2, TMPRSS2 and PAK1 signaling pathways; in addition, antiviral activity has been proven in vitro and in vivo. This is a pilot randomized study that aims to assess the impact of using Brazilian green propolis extract against the deleterious effects of the new coronavirus.
Description: Composite clinical outcome with oxygen therapy dependency time (in days) or hospitalization time (in days) after randomization.
Measure: Composite clinical outcome with oxygen therapy dependency time or hospitalization time Time: 1-28 daysDescription: We will evaluate the presence or absence of symptoms related to the use of propolis through a questionnaire.
Measure: Percentage of participants with adverse events during the use of propolis Time: 1-28 daysDescription: Assess the degree of acute kidney injury according to KDIGO (through serum creatinine or urine output).
Measure: Rate and severity of acute kidney injury during the study Time: 1-28 daysDescription: Assess need or not for renal replacement therapy.
Measure: Renal replacement therapy. Time: 1-28 daysDescription: Describe the time needed for vasopressors in days after randomization
Measure: Rate of need for vasopressor use Time: 1-28 daysDescription: Assess length of stay in the ICU after randomization in days
Measure: Need for intensive care unit (ICU) Time: 1-28 daysDescription: Rate of readmission to the ICU after randomization
Measure: Intensive care unit (ICU) readmission Time: 1-28 daysDescription: Assess the need for mechanical ventilation in days after randomization.
Measure: Invasive oxygenation time Time: 1-28 daysDescription: Evaluate the variation in serum levels of c-reactive protein over the 7 days after randomization
Measure: Variation of plasma c-reactive protein Time: 1-7 days